# Emtricitabine and tenofovir disoproxil fumarate

NDC: 70771-1622
Generic name: Emtricitabine and tenofovir disoproxil fumarate
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20210701

FDA application: ANDA212689

## Active ingredients

- EMTRICITABINE: 167 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1622"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1622
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0ee89b6-72c3-4b99-8d1c-d7473f1d5ef3